The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek JJ,
Spitzer E,
Jüni P,
Hamm C,
Steg PG,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
State of the art: optimal medical therapy – competing with or complementary to revascularisation in patients with coronary artery disease?
August 25, 2017 | 10.4244/EIJ-D-17-00463
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
Iqbal J,
Verheye S,
Abizaid A,
Ormiston J,
De Vries T,
Morrison L,
Toyloy S,
Fitzgerald P,
Windecker S,
Serruys P
December 9, 2016 | 10.4244/EIJY15M10_04
Clinical outcomes of “complete, partially complete, and incomplete” revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents
Zhang Y-J,
Iqbal J,
Ye F,
Zhang J,
Bourantas C,
Pan D-R,
Tian N,
Kan J,
Qian X-S,
Ding S,
Li F,
Zhang A,
Liu Y,
Muramatsu T,
Onuma Y,
Garcia-Garcia HM,
Serruys P,
Chen S
October 10, 2016 | 10.4244/EIJY15M12_06
Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial
Zhang Y-J,
Bourantas C,
Muramatsu T,
Iqbal J,
Farooq V,
Diletti R,
Campos C,
Onuma Y,
Garcia-Garcia HM,
Serruys P
October 20, 2014 | 10.4244/EIJV10I6A118
Coronary stents seeded with human trophoblastic endovascular progenitor cells show accelerated strut coverage without excessive neointimal proliferation in a porcine model
Raina T,
Iqbal J,
Arnold N,
Moore H,
Aflatoonian B,
Walsh J,
Whitehouse S,
Al-Lamee R,
Francis S,
Gunn J
October 20, 2014 | 10.4244/EIJV10I6A123
Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial
Ishibashi Y,
Onuma Y,
Muramatsu T,
Nakatani S,
Iqbal J,
Garcia-Garcia HM,
Bartorelli A,
Whitbourn R,
Abizaid A,
Serruys P
August 19, 2014 | 10.4244/EIJV10I4A78
Transcatheter aortic valve update 2013
September 15, 2013 | 10.4244/EIJV9SSA16
Latest news
AHEAD OF PRINT
LVOT calcification in TAVI : a post hoc analysis from the SOLVE-TAVI trial
FREE ARTICLE - Serdar Farhan et al
August 9, 2022
NEW ISSUE
The 16th EBC Expert consensus; ticagrelor or aspirin monotherapy 1 year after PCI; vasospasm and atherosclerosis in ANOCA; lifetime valve journey; and more…
August 5, 2022
AHEAD OF PRINT
RADIANCE-HTN SOLO 36-month analysis
FREE ARTICLE - Florian Rader et al
August 1, 2022
AHEAD OF PRINT
Percutaneous left atrial appendage closure with superior vascular access
FREE ARTICLE - Roberto Galea et al
August 4, 2022
AHEAD OF PRINT
Dual ProGlide vs ProGlide and FemoSeal after TAVI
FREE ARTICLE - Jonas M.D. Gmeiner et al
July 29, 2022
AHEAD OF PRINT
Stent thrombosis in comatose OHCA (ST-OHCA Study)
FREE ARTICLE - Martin Rauber et al
July 25, 2022
AHEAD OF PRINT
Evolocumab and periprocedural microvascular damage
FREE ARTICLE - Masaharu Ishihara et al
July 15, 2022